S'abonner

Association of Primary Care Shortage Areas with Adverse Outcomes after Pediatric Liver Transplant - 22/06/22

Doi : 10.1016/j.jpeds.2022.03.007 
Holly P. Shifman, MS 1, Erika Rasnick, MS 2, Chiung-Yu Huang, PhD 3, Andrew F. Beck, MD, MPH 2, 4, John Bucuvalas, MD 5, 6, Jennifer C. Lai, MD, MBA 7, Sharad I. Wadhwani, MD, MPH 8,
1 School of Medicine, Oakland University William Beaumont, Rochester, MI 
2 Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 
3 Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA 
4 Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH 
5 Division of Hepatology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 
6 Division of Hepatology, Department of Pediatrics, Kravis Children's Hospital, New York, NY 
7 Division of Gastroenterology, Hepatology & Nutrition, Department of Medicine, University of California San Francisco, San Francisco, CA 
8 Division of Pediatric Gastroenterology, Hepatology & Nutrition, Department of Pediatrics, University of California San Francisco, San Francisco, CA 

Reprint requests: Sharad I. Wadhwani, MD, MPH, 744 52nd St, Oakland, CA 94609.744 52nd StOaklandCA94609

Abstract

Objective

To characterize associations between living in primary care shortage areas and graft failure/death for children after liver transplantation.

Study design

This was an observational study of all pediatric patients (aged <19 years) who received a liver transplant between January 1, 2005, and December 31, 2015 in the US, with follow-up through January 2019 (N = 5964). One hundred ninety-five patients whose home ZIP code could not be matched to primary care shortage area status were excluded. The primary outcome was a composite endpoint of graft failure or death. We used Cox proportional hazards to model the associations between health professional shortage area (HPSA) and graft failure/death.

Results

Children living in HPSAs had lower estimated graft survival rates at 10 years compared with those not in HPSAs (76% vs 80%; P < .001). In univariable analysis, residence in an HPSA was associated with a 22% higher hazard of graft failure/death than non-residence in an HPSA (hazard ratio [HR], 1.22; 95% CI, 1.09-1.36; P < .001). Black children from HPSAs had a 67% higher hazard of graft failure/death compared with those not in HPSAs (HR, 1.67; 95% CI, 1.29 to 2.16; P = .006); the effect of HPSA status was less pronounced for White children (HR, 1.11; 95% CI, 0.98-1.27; P = .10).

Conclusions

Children living in primary care shortage areas are at increased risk of graft failure and death after liver transplant, and this risk is particularly salient for Black children. Future work to understand how living in these regions contributes to adverse outcomes may enable teams to mitigate this risk for all children with chronic illness.

Le texte complet de cet article est disponible en PDF.

Keywords : liver transplant, primary care availability, pediatric chronic disease, structural racism

Abbreviations : %<FPL, HPSA, HR, HRSA, MELD, PCP, PELD, SRTR


Plan


 Supported in part by the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)/NASPGHAN Foundation (H.S.), the National Institutes of Health (NIH) (Grant T32 DK 7727-24; PI Lee Denson, support for S.W.), the University of California San Francisco Liver Center (Grant P30 DK026743, to S.W., C-Y.H., and J.L.), and the National Center for Advancing Translational Sciences (Award KL2TR001870, to S.W.). The content is solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The authors declare no conflicts of interest.
 Portions of this study were presented as a poster presentation at the NASPGHAN virtual Annual Meeting on December 15, 2021 and also being presented as an oral presentation at the Pediatric Academic Societies (PAS) Meeting, April 23, 2022, Denver, Colorado.


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 246

P. 103 - juillet 2022 Retour au numéro
Article précédent Article précédent
  • High Impact of Pediatric Inflammatory Bowel Disease on Caregivers’ Work Productivity and Daily Activities: An International Prospective Study
  • Renz C.W. Klomberg, Martine A. Aardoom, Polychronis Kemos, Dimitris Rizopoulos, Frank M. Ruemmele, Nicholas M. Croft, Lissy de Ridder, Mattias Neyt, the PIBD-SET Quality consortium, Dan Turner, Gili Focht, Janneke Samsom, Gigi Veereman, Sibylle Koletzko, Annecarin Brückner, Arie Levine, Richard Russell, Anne Griffiths, Marina Aloi, Thomas Walters, Michael Walker
| Article suivant Article suivant
  • Acute Pancreatitis Is Associated with Increased Risk of In-Hospital Mortality and Health Care Utilization Among Pediatric Patients with Hematopoietic Stem Cell Transplantation
  • Aravind Thavamani, Krishna Kishore Umapathi, Jignesh Dalal, Thomas J. Sferra, Senthilkumar Sankararaman

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.